Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome.: Application to structure-based analogue design

被引:35
作者
Furet, P [1 ]
Imbach, P [1 ]
Fürst, P [1 ]
Lang, M [1 ]
Noorani, M [1 ]
Zimmermann, J [1 ]
Garcia-Echeverría, C [1 ]
机构
[1] Novartis Pharmaceut Inc, Oncol Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/S0960-894X(01)00206-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 2-aminobenzylstatine derivative 1 is a 20S proteasome inhibitor of a novel chemical type identified by high throughput screening. The compound specifically inhibits the chymotrypsin-like catalytic activity of the human proteasome with an IC50 value in the micromolar range. Using the crystal structure of the yeast proteasome we modeled the structure of the human proteasome in complex with 1. As one of the first applications of the model in our oncology programme targeting the proteasome, we designed an analogue of the inhibitor having enhanced stacking/hydrophobic interactions with the enzyme. One order of magnitude in inhibitory potency was gained. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1321 / 1324
页数:4
相关论文
共 11 条
[1]  
BILLICH A, 1995, ANTIVIR CHEM CHEMOTH, V6, P327, DOI 10.1177/095632029500600507
[2]   DEFINITION AND DISPLAY OF STERIC, HYDROPHOBIC, AND HYDROGEN-BONDING PROPERTIES OF LIGAND-BINDING SITES IN PROTEINS USING LEE AND RICHARDS ACCESSIBLE SURFACE - VALIDATION OF A HIGH-RESOLUTION GRAPHICAL TOOL FOR DRUG DESIGN [J].
BOHACEK, RS ;
MCMARTIN, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) :1671-1684
[3]   Pharmacological proteasome inhibitors and their therapeutic potential [J].
Dou, QP ;
Nam, S .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) :1263-1272
[4]  
Elliot P J, 1999, Curr Opin Drug Discov Devel, V2, P484
[5]   A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome [J].
Garcia-Echeverría, C ;
Imbach, P ;
France, D ;
Fürst, P ;
Lang, M ;
Noorani, M ;
Scholz, D ;
Zimmermann, J ;
Furet, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) :1317-1319
[6]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[7]   MACROMODEL - AN INTEGRATED SOFTWARE SYSTEM FOR MODELING ORGANIC AND BIOORGANIC MOLECULES USING MOLECULAR MECHANICS [J].
MOHAMADI, F ;
RICHARDS, NGJ ;
GUIDA, WC ;
LISKAMP, R ;
LIPTON, M ;
CAUFIELD, C ;
CHANG, G ;
HENDRICKSON, T ;
STILL, WC .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :440-467
[8]   X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: Agreement of time-resolved spectroscopy and molecular dynamics simulations [J].
Ringhofer, S ;
Kallen, J ;
Dutzler, R ;
Billich, A ;
Visser, AJWG ;
Scholz, D ;
Steinhauser, O ;
Schreiber, H ;
Auer, M ;
Kungl, AJ .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (04) :1147-1159
[9]   ON SIZE OF ACTIVE SITE IN PROTEASES .I. PAPAIN [J].
SCHECHTER, I ;
BERGER, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 27 (02) :157-+
[10]   WHAT IF - A MOLECULAR MODELING AND DRUG DESIGN PROGRAM [J].
VRIEND, G .
JOURNAL OF MOLECULAR GRAPHICS, 1990, 8 (01) :52-&